Clinical Trials Browser

Phase NA × Breast Neoplasms × ribociclib × Clear all

NCT06810492 2025-03-17

The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

Phase NA Not yet recruiting

Breast Neoplasms